In the continuous pursuit of innovative cancer treatments, we published a study titled "Ultrasound Stiffness and Perfusion Markers Correlate with Tumor Volume Responses to Immunotherapy." This groundbreaking research explores the potential of mechanotherapy to improve and predict the efficacy of immunotherapy in cancer treatment. Using ultrasound, we have discovered that tumor stiffness and perfusion biomarkers can accurately predict the response to immunotherapy, effectively categorizing tumors into responders and non-responders.
The full study is available for review and further research. https://doi.org/10.1016/j.actbio.2023.06.007
Comments